Michael Serbin

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 4

Top Topics

Parkinson Disease

Replacement Therapy

Top Venues

Journal of medical economics

Patient preference and adherence

This page only lists publications with an associated author ORCID identifier.

Publications

Michael Serbin, Connie Marras, Carol A Mansfield, Colton Leach, Charles Yonan, Margaret Sheehan, Anne Donnelly, Olga Klepitskaya
Patients' Preferences for Adjunctive Parkinson's Disease Treatments: A Discrete-Choice Experiment. Patient preference and adherence 17 (2023)
Ryan N Hansen, Kangho Suh, Michael Serbin, Chuck Yonan, Sean D Sullivan
Cost-effectiveness of opicapone and entacapone in reducing OFF-time in Parkinson's disease patients treated with levodopa/carbidopa. Journal of medical economics 24 (1) (2021)
Michael Serbin, Charles Yonan, Michael L Ganz
In Reply to Xue W, Ribalov R, Zhou Z-Y, et al. Re: Ganz ML, Chavan A, Dhanda R, et al. Cost-effectiveness of valbenazine compared with deutetrabenazine for the treatment of tardive dyskinesia. J Med Econ. 2021;24(1):103-113. Journal of medical economics 24 (1) (2021)
Michael L Ganz, Ameya Chavan, Rahul Dhanda, Michael Serbin, Charles Yonan
Cost-effectiveness of valbenazine compared with deutetrabenazine for the treatment of tardive dyskinesia. Journal of medical economics 24 (1) (2021)